Compare NVNI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVNI | COSM |
|---|---|---|
| Founded | 2019 | 2009 |
| Country | Brazil | United States |
| Employees | 477 | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 12.9M |
| IPO Year | N/A | 2009 |
| Metric | NVNI | COSM |
|---|---|---|
| Price | $0.99 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 385.2K | ★ 11.4M |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | $6.67 | $54.08 |
| Revenue Next Year | $26.67 | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.31 | $0.16 |
| 52 Week High | $4.94 | $1.32 |
| Indicator | NVNI | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 52.19 |
| Support Level | $0.94 | N/A |
| Resistance Level | $1.27 | $0.28 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 82.86 | 64.26 |
Nvni Group Ltd, through its existing subsidiary companies, operates business-to-business software-as-a-service (B2B SaaS) products in Brazil, serving a diversified customer base of small and mid-sized enterprises across vertical markets. The Group's core business activity is providing a SaaS platform model focused on the software delivery method of cloud-based software applications to its customers. The Group generates revenues and profits from SaaS platform subscription services, data analytics services, set-up and other services. The Group has a single operating and reportable segment, multi-vertical SaaS solution model. The Group operates and generates revenue from Brazil.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.